Last reviewed · How we verify
NCT04510883
Usage and Health Effects of Embodied Conversational Agents Among Older Adults
NA trial testing PACO in Eating Behavior in 52 participants. Completed in 30 December 2020.
30 December 2020
Quick facts
| Lead sponsor | Wageningen University and Research |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | sequential |
| Masking | single |
| Primary purpose | supportive care |
| Enrollment | 52 |
| Start date | 13 July 2020 |
| Primary completion | 30 December 2020 |
| Estimated completion | 30 December 2020 |
| Sites | 1 location across Netherlands |
Drugs / interventions tested
- PACO
- Waiting list + PACO
Conditions studied
- Eating Behavior — all drugs for Eating Behavior →
- Loneliness — all drugs for Loneliness →
- Technology Use — all drugs for Technology Use →
Sponsor
Wageningen University and Research
Who can join
65 and older, any sex, with Eating Behavior or Loneliness. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Rationale: Embodied Conversational Agents (ECAs), could be a highly effective medium to address health behaviour change among older adults. As compliance to health advice is important for positive health outcomes, successful design of persuasive ECAs can have huge health benefits. However, insights in the mechanisms underlying usage and health behaviour change via ECAs are lacking. Objective: The objective is to unravel the mechanisms behind the use of an ECA intervention, and understand the mechanism behind the observed behaviour change Study design: A randomized staggered-entry waitlist-controlled trial will be carried out. Study population: The study population consist of Dutch-speaking older adults, who live independently, are without partner, are retired, 65+ and possess basic computer skills. Intervention: The application PACO has been created for (and with) older adults with the goal to motivate them to improve their eating behaviour and decrease their feelings of loneliness. Main study parameters/endpoints: The main study parameters are use, loneliness, and eating behaviour. Nature and extent of the burden and risks associated with participation, benefit and group relatedness: Subjects are not exposed to any risks, nor have they any costs. They do have to fill in questionnaires and use the application. The duration and data collection moments are needed to gain a fine-grained understanding of the use, relationship development and health change process. For subjects, the main benefit is to gain insight in their health behaviour via the PACO-application. Although this might be experienced as confronting by some. The technology was developed based on sound theories, with input from the target group, so the investigators expect positive experiences and an improvement in participants loneliness and eating behaviour. However, this can only be proven after the study.
Publications & conference data
2 peer-reviewed publications reference this trial (live from Europe PMC):
-
Use and Effect of Embodied Conversational Agents for Improving Eating Behavior and Decreasing Loneliness Among Community-Dwelling Older Adults: Randomized Controlled Trial.
Kramer LL, van Velsen L, Clark JL, Mulder BC, et al · · 2022 · cited 13× · PMID 35404255 · DOI 10.2196/33974 -
Use and Effect of Web-Based Embodied Conversational Agents for Improving Eating Behavior and Decreasing Loneliness Among Community-Dwelling Older Adults: Protocol for a Randomized Controlled Trial.
Kramer LL, Mulder BC, van Velsen L, de Vet E. · · 2021 · cited 9× · PMID 33404513 · DOI 10.2196/22186
Verify or expand the search:
- PubMed search for NCT04510883
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Eating Behavior
Currently open trials in the same condition.
- NCT06551974 — INTERconNEcT-Eds: a Guided Self-help Mobile App to Improve Outcome in Eating Disorders · NA · recruiting
- NCT07348432 — The diabEAT Study: Insulin dElivery Technologies And eaTing Behaviours in People With Type 1 Diabetes · recruiting
- NCT06175988 — Visceral Adiposity, Vagal Tone and Food Preferences: a Pilot Study · recruiting
- NCT06145009 — Time Restricted Eating, Eating Behaviors, and Cardiometabolic Risk in Emerging Adult Women · NA · recruiting
- NCT06108128 — Food for Thought: Executive Functioning Around Eating Among Children · NA · recruiting
Other Wageningen University and Research trials
Trials by the same sponsor.
- NCT06945016 — Monitoring Nutritional Consequences of Obesity Treatment on Women's Health · recruiting
- NCT06665464 — Bioavailability of Omega-3 Fatty Acids From Fish Oil Supplements · NA · completed
- NCT05762965 — Effect of Galacto-oligosaccharides (GOS) on Faecal Gut Microbiota in Adult Women · NA · completed
- NCT05773625 — JITAIs: Optimization of Effectiveness · NA · completed
- NCT05574530 — Vitamin (VIT) for Vigilance Study · NA · unknown
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04510883 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Wageningen University and Research
- Last refreshed: 8 April 2021
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04510883.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing